A successful biotechnology investment professional with over two decades of experience in the field, Dr. Lindsay Rosenwald also maintains an unwavering dedication to community service and charitable giving. Through his Rosenwald Foundation, he has donated millions of dollars to worthwhile causes across the United States. Dr. Lindsay Rosenwald also holds a seat on the Board of Visitors of the Smeal College of Business at Penn State University.
Today, Dr. Rosenwald serves as a partner and co-founder of an investment partnership In this role, he oversees all investment activities of the asset management firm, which concentrates primarily on the healthcare industry. Over the course of his career, Dr. Lindsay Rosenwald has founded and financed multiple successful biotechnology companies, which have licensed and developed more than 100 medicines in clinical-stage trials. In particular, his companies have developed effective treatments for disorders such as influenza, schizophrenia, obesity, and infant respiratory distress syndrome.
Earlier in his career, Dr. Lindsay Rosenwald worked as a co-founder and original financial backer of Cougar Biotechnology, which developed a pharmaceutical treatment for previously untreatable prostate cancer. Since its development, the drug has improved the prognosis for thousands of patients with end-stage cancer. Dr. Rosenwald also played a vital role in the development of arsenic trioxide, which is highly effective in the treatment of acute promyelocytic leukemia.
Before starting his career in biotechnology finance, Dr. Rosenwald received a bachelor of science in finance from Penn State University and a doctor of medicine from the Temple University School of Medicine.